Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |